Document is current
Any future updates will be listed below
-
Authors
Buradagunta, Christopher Staffi
Garacci, Zhuping
D’Souza, Anita https://orcid.org/0000-0002-1092-5643
Dhakal, Binod https://orcid.org/0000-0002-4377-9742
Devata, Sumana
Janz, Siegfried https://orcid.org/0000-0002-2229-5511
Thrift, Aaron P.
Hari, Parameswaran https://orcid.org/0000-0002-8800-297X
Stolley, Melinda
Dong, Jing https://orcid.org/0000-0001-9856-5963
- License Information
-
More Information
Article History
Received: 17 March 2022
Revised: 27 April 2022
Accepted: 11 May 2022
First Online: 25 May 2022
Competing interests
: AD reports the following: Research funding (Institution)- Sanofi, Prothena, Caelum, Takeda, Janssen, Regeneron, TeneoBio, Abbvie, Consultant- Janssen, Ad Board- Pfizer, BMS.
